Seoul, as a global hub for the bio-health industry, is witnessing an unprecedented surge in demand for next-generation Probiotics and Prebiotics. With the aging population in Gyeonggi-do and the ultra-competitive "wellness culture" in Gangnam, microbiome products have transitioned from basic supplements to essential lifestyle biotics. Our factory provides Seoul-based brands with the "Information Gain" required to outpace competitors through strain specificity and high-CFU stability.
Recent data indicates that the South Korean probiotic market is projected to reach $1.2 billion by 2026. For businesses in Seoul, the focus is shifting toward psychobiotics (mental health) and skin-biotics (K-Beauty integration). Shanghai Aeterna Biotech supports these specific niches with specialized strains like Lactobacillus acidophilus and advanced Xylo-oligosaccharides (XOS).
Efficiency is the heartbeat of the Seoul business environment. Our manufacturing facility in Shanghai offers a geographical and logistical masterstroke for Korean importers.
By utilizing the Shanghai-Incheon shipping route, we ensure that our probiotics—which are sensitive to temperature and time—reach Seoul warehouses with maximum viability. Our integrated Logistics Information Management System provides real-time tracking, ensuring that "just-in-time" manufacturing becomes a reality for your brand.
Our R&D roadmap includes the development of micro-encapsulation technology, ensuring that probiotics survive the gastric acid transit. Using AI-driven screening, we identify the most synergistic combinations of Prebiotics (FOS/XOS) and Probiotic strains to create "Super Bifidus Factors" tailored for the East Asian microbiome profile.
Shanghai Aeterna Biotech Co., Ltd. is a leading, reliable, and professional manufacturer specializing in fine chemicals, plant extracts, enzyme preparations, and nutritional ingredients. Our expertise spans research, development, production, and global sales. With decades of experience, we have built a solid reputation for delivering high-quality products and innovative solutions to a wide range of industries.
Our facilities are equipped with state-of-the-art production and testing equipment, allowing us to meet the highest industry standards. Through years of serving European and American markets, our QA/QC team has gained extensive experience in impurity analysis, precise control of flavor and fragrance formulations, and rigorous quality management. Our commitment to safety and reliability ensures that every product meets the expectations of both clients and end consumers.
With modern production facilities and advanced logistics, Shanghai Aeterna Biotech manufactures thousands of tons of premium products annually. Our close partnerships with major international freight forwarders in Shanghai ensure timely global distribution. The integration of China’s advanced Logistics Information Management System enables us to provide fast, reliable, and cost-effective shipping solutions for our clients worldwide.
Physical and Chemical Tests
Moisture Detection
Assay Detection
PH Meter
Electrical Conductivity Meter
Mould Incubator
High Temperature Sterilizing Pot
Analytical Balance
Drying Oven
Ash Detection Machine
HPLC Detection Machine
UV Detection Machine
UV Spectrophotometer
Electric Thermostatic Drying Oven
Waters High Performance Liquid Chromatograph
Box Type Electric Furnace
Atomic Absorption Spectrophotometer
Ultraviolet Camera ObscuraA: We provide comprehensive COA, ISO, and GMP documentation. Our strains are screened to match the MFDS approved species list, and we offer stability testing data at 25°C/60% RH to ensure shelf-life compliance in Korea's climate.
A: Production typically takes 7-15 days depending on the formulation. Shipping from Shanghai Port to Incheon Port takes approximately 1-2 days, making us one of the fastest international suppliers for the Seoul market.
A: Yes. We specialize in "Dual-Action" formulations—combining gut health probiotics with skin-improving plant extracts, which are highly popular in the Seoul beauty supplement market.
A: Absolutely. Our state-of-the-art freeze-drying technology allows us to provide stable concentrations of up to 200 Billion CFU/g for strains like Lactobacillus acidophilus.
As we move toward 2025, Shanghai Aeterna Biotech is investing in Postbiotics and Precision Nutrition. For our partners in Seoul, this means access to non-viable microbial cells that offer the same health benefits with even greater shelf stability—perfect for Seoul's innovative "ambient-stable" functional beverage sector. We invite you to be part of this microbiome revolution.
Aeterna Biotech
